STOCK TITAN

VYGR (NASDAQ: VYGR) holder plans 4,569-share Rule 144 sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder in VYGR has filed a notice of proposed sale under Rule 144 for 4,569 common shares through Fidelity Brokerage Services on or about 02/10/2026, to be sold on NASDAQ. The filing shows an aggregate market value of 17598.87 for these shares, compared with 55,600,084 shares of the same class outstanding.

The shares to be sold were acquired on 02/09/2026 via restricted stock vesting from the issuer as compensation, indicating this is a sale of recently vested equity rather than a market purchase.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many VYGR shares are planned to be sold under this Form 144?

The filing covers a proposed sale of 4,569 common shares of VYGR. These shares have an aggregate market value of 17598.87 and are to be sold through Fidelity Brokerage Services on NASDAQ, according to the Rule 144 notice.

How were the VYGR shares in this Form 144 acquired?

The 4,569 VYGR common shares were acquired on 02/09/2026 through restricted stock vesting. The filing notes the issuer granted these shares as compensation, meaning they represent equity-based pay rather than shares bought in the open market.

When is the planned sale date for the VYGR shares in this Form 144?

The notice lists an approximate sale date of 02/10/2026 for the 4,569 VYGR common shares. The shares are expected to be sold on the NASDAQ market through Fidelity Brokerage Services, subject to Rule 144 conditions.

What is the aggregate market value of the VYGR shares to be sold?

The proposed sale of 4,569 VYGR common shares has an aggregate market value of 17598.87. This figure is based on the market price at the time referenced in the notice and is used to quantify the size of the planned transaction.

How many VYGR shares are outstanding compared with this Form 144 sale?

The filing states that 55,600,084 common shares of VYGR are outstanding. The proposed sale of 4,569 shares is small relative to this total, providing context on the holding’s scale versus the company’s overall share count.

Which broker and exchange are involved in this VYGR Form 144 sale?

The notice identifies Fidelity Brokerage Services LLC as the broker for the proposed sale of 4,569 VYGR common shares. The shares are expected to be sold on the NASDAQ exchange, as disclosed in the filing.

Voyager Therapeutics Inc

NASDAQ:VYGR

VYGR Rankings

VYGR Latest News

VYGR Latest SEC Filings

VYGR Stock Data

206.28M
46.51M
16.52%
59.95%
5.31%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
LEXINGTON